Key result
Acrolein inhalation suppresses circulating progenitor cells and prevents VEGF-induced mobilization in mice.
OBJECTIVE: Acrolein is a toxic chemical present in tobacco, wood, and coal smoke, as well as automobile exhaust. Because exposure to these pollutants is associated with an increase in cardiovascular disease risk, we studied the effects of acrolein on Flk-1(+)/Sca-1(+) cells that are involved in vascular repair. METHODS AND RESULTS: In adult male C57BL/6 mice, inhalation of acrolein (1 part per million [ppm], 6 hours/day for 4 days or 5 ppm for 2 or 6 hours) led to the formation of protein-acrolein adducts in the bone marrow and diminished levels of plasma nitric oxide metabolites and circulating Flk-1(+)/Sca-1(+) but not Sca-1(+)-only cells. Acrolein exposure increased the number of apoptotic Flk-1(+)/Sca-1(+) cells in circulation and increased bone marrow-derived cells with endothelial characteristics (DiI-ac-low-density lipoprotein [DiI-acLDL]/UE-lectin and Flk-1(+)/Sca-1(+)) in culture. Deficits in the circulating levels of Flk-1(+)/Sca-1(+) cells were reversed after 7 days of recovery in acrolein-free air. Exposure to acrolein blocked vascular endothelial growth factor (VEGF)/AMD3100-stimulated mobilization of Flk-1(+)/Sca-1(+) but not Sca-1(+)-only cells and prevented VEGF-induced phosphorylation of Akt and endothelial nitric oxide synthase in the aorta. CONCLUSIONS: Inhalation of acrolein increases apoptosis and suppresses the circulating levels of Flk-1(+)/Sca-1(+) cells while increasing these cells in the bone marrow and preventing their mobilization by VEGF. Exposure to acrolein-rich pollutants could impair vascular repair capacity.
No takes yet. Share an insight, caveat, or question.
Wheat et al. (2011) studied Vascular repair impairment due to acrolein inhalation. Acrolein inhalation vs. Acrolein-free air was evaluated on Circulating levels and VEGF/AMD3100-stimulated mobilization of Flk-1(+)/Sca-1(+) cells. Acrolein inhalation (1 ppm for 4 days or 5 ppm for 2-6 hours) in mice suppressed circulating Flk-1(+)/Sca-1(+) cells (reversible after 7 days) and blocked their VEGF-induced mobilization.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: